Skip to content
Search

Latest Stories

Surge in stroke cases could cost UK £75bn by 2035, charity warns

Surge in stroke cases could cost UK £75bn by 2035, charity warns

By 2035, there will be 151,000 hospital admissions due to stroke every year, averaging 414 admissions per day

In the next 10 years, the incidence of first-time stroke cases in the UK is projected to increase by 60 per cent, costing the government £75bn in healthcare and lost productivity, a charity has suggested.

A new manifesto published by the Stroke Association has urged the next UK government to make stroke “the priority”, stressing that the next decade is crucial for stroke prevention, treatment and recovery.


Currently, stroke is the UK’s fourth biggest killer and a leading cause of disability. On a daily basis, 281 individuals experience a stroke. Next year, the cost of stroke in the UK will be £43 billion.

The charity predicted that by 2035, there will be 151,000 hospital admissions due to stroke every year, averaging 414 admissions per day, with 42,000 people estimated to die every year.

In 2035, the UK is projected to have 2.1 million stroke survivors, imposing a financial burden of £75 billion on the public purse, nearly half the current NHS budget.

As 1 in 4 strokes happen to people of working age, it causes a loss in productivity of £1.6 billion per year. This figure is expected to increase 136 per cent by 2035. With an estimated 173,000 stroke survivors anticipated to be missing from the workforce, the economy will lose billions, the charity warned.

Juliet Bouverie, the chief executive of the Stroke Association said: “If the next government fails to tackle prevention, treatment, and recovery at the root, then stroke will become the most avoidable burden on the NHS.”

She emphasised the need for a substantial increase in the number of medical professionals, including doctors, nurses, physiotherapists, speech therapists, and others focused exclusively on stroke, warning that failure to do so could result in many more deaths, increased disability, and a loss of independence among patients.

Stroke is preventable

According to Bouverie, a range of lifestyle factors including rising alcohol consumption and low exercise, alongside the aging population and inadequate preventive measures, will contribute to the anticipated increase in strokes over the next decade.

However, she stated that with the right investment, stroke is “preventable, treatable, and recoverable.”

In 2000, stroke was the second leading cause of death in the UK. By making stroke a national priority reflected in local resources, stroke mortality was halved by 2010. Change is possible,” Bouverie said.

“We have the knowledge and the treatments, but we do not yet have the political will to get this to patients.

“Any party wanting to transform health in our country should place stroke at the top of its priority list. The next government has the choice to stop stroke or let it spiral. We need to see the start of real change,” she added.

The Stroke Association is calling on Department of Health and Social Care (DHSC) to publish a funded stroke prevention plan to support people of all ages to reduce their risk of stroke.

The charity highlighted that early detection and management of risk factors can significantly reduce the cost of stroke on the NHS and wider society.

Furthermore, it asked the DHSC to ensure that the stroke treatment thrombectomy is universally available 24/7.

“Thrombectomy is a game-changing and cost-effective treatment to remove the blood clot in the brain which has caused the stroke, restoring blood flow. It can dramatically improve recovery poststroke and significantly reduces the chance of disabilities like paralysis, visual impairment and communication difficulties,” it said.

It also urged the UK government to address access to rehabilitation and prioritise equitable delivery of psychological and emotional support for stroke survivors across the UK.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less